Variant report
Variant | nsv516124 |
---|---|
Chromosome Location | chr4:44968603-44998994 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1948587 | chr4:44968603-44968604 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs543676155 | chr4:44968618-44968619 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs369125921 | chr4:44968640-44968641 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs561952429 | chr4:44968785-44968786 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530225730 | chr4:44968880-44968881 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs562967388 | chr4:44968892-44968893 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs74976486 | chr4:44968900-44968901 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs78549449 | chr4:44968901-44968902 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs532955039 | chr4:44968925-44968926 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs549897773 | chr4:44968942-44968943 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563423012 | chr4:44968992-44968993 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs150946157 | chr4:44968994-44968995 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs68022841 | chr4:44969011-44969012 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs201007154 | chr4:44969014-44969015 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs139577440 | chr4:44969045-44969046 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs541324994 | chr4:44969086-44969087 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs567619256 | chr4:44969107-44969108 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs368354602 | chr4:44969220-44969221 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs35345808 | chr4:44969233-44969234 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs35975418 | chr4:44969235-44969236 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs532963789 | chr4:44969248-44969249 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs149711689 | chr4:44969257-44969258 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs7672928 | chr4:44969268-44969269 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs539046726 | chr4:44969275-44969276 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs557155280 | chr4:44969278-44969279 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs186903618 | chr4:44969295-44969296 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs191694739 | chr4:44969336-44969337 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs555554817 | chr4:44969354-44969355 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs530257960 | chr4:44969366-44969367 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs541295706 | chr4:44969374-44969375 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs73812455 | chr4:44969413-44969414 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs372012669 | chr4:44969463-44969464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs545021633 | chr4:44969475-44969476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369328524 | chr4:44969487-44969488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs35250483 | chr4:44969488-44969489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs201109830 | chr4:44969502-44969503 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs141423958 | chr4:44969508-44969509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs182536171 | chr4:44969520-44969521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs10007607 | chr4:44969521-44969522 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs561108496 | chr4:44969526-44969527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs188050100 | chr4:44969530-44969531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs537643023 | chr4:44969557-44969558 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs531125023 | chr4:44969591-44969592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs193056557 | chr4:44969727-44969728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs369509948 | chr4:44969736-44969737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs11946177 | chr4:44969737-44969738 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs146447171 | chr4:44969782-44969783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs375874018 | chr4:44969786-44969787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs114702207 | chr4:44969809-44969810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs76805697 | chr4:44969819-44969820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Gastric cancer | 16891809 | CNVD |
Multiple myeloma | 17550852 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:44967200-44969400 | Enhancers | HMEC | breast |
2 | chr4:44968000-44975800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr4:44970200-44971000 | Enhancers | Fetal Heart | heart |
4 | chr4:44975800-44976600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr4:44984200-44984400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr4:44984200-44984400 | Enhancers | HMEC | breast |
7 | chr4:44984400-44984800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr4:44984400-44985200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
9 | chr4:44984400-44985400 | Weak transcription | HMEC | breast |
10 | chr4:44985200-44986600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
11 | chr4:44985200-44988600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
12 | chr4:44985400-44988000 | Enhancers | HMEC | breast |
13 | chr4:44985800-44986400 | Enhancers | Fetal Stomach | stomach |
14 | chr4:44986600-44987800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
15 | chr4:44987800-44988400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
16 | chr4:44988600-44993400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
17 | chr4:44993400-44994000 | Strong transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
18 | chr4:44994000-44997000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
19 | chr4:44996800-44997400 | Enhancers | HMEC | breast |
20 | chr4:44997000-44998800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
21 | chr4:44998000-44998800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
22 | chr4:44998000-44998800 | Enhancers | Placenta Amnion | Placenta Amnion |
23 | chr4:44998800-45006200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |